B
Bartha Maria Knoppers
Researcher at McGill University
Publications - 516
Citations - 54285
Bartha Maria Knoppers is an academic researcher from McGill University. The author has contributed to research in topics: Biobank & Population. The author has an hindex of 63, co-authored 491 publications receiving 44965 citations. Previous affiliations of Bartha Maria Knoppers include Catholic University of the Sacred Heart & University of Alberta.
Papers
More filters
Journal ArticleDOI
Envisioning Implementation of a Personalized Approach in Breast Cancer Screening Programs: Stakeholder Perspectives
TL;DR: This study explores the acceptability of different proposals for each step of the trajectory for women in the healthcare system should a personalized approach to breast cancer screening be implemented in the province of Quebec.
Posted ContentDOI
Failure to replicate the association of rare loss-of-function variants in type I IFN immunity genes with severe COVID-19
Gundula Povysil,Guillaume Butler-Laporte,Ning Shang,Chen Weng,Atlas Khan,Manal Alaamery,Manal Alaamery,Tomoko Nakanishi,Sirui Zhou,Vincenzo Forgetta,Robert Eveleigh,Mathieu Bourgey,Naveed Aziz,Steven J.M. Jones,Bartha Maria Knoppers,Stephen W. Scherer,Lisa J. Strug,Pierre Lepage,Jiannis Ragoussis,Guillaume Bourque,Jahad Alghamdi,Nora Aljawini,Nora Aljawini,Nour Albes,Nour Albes,Hani M. Al-Afghani,Bader Alghamdi,Mansour Almutair,Ebrahim Mahmoud,Leen Abu Safie,Hadeel El Bardisy,Fawz S. Al Harthi,Abdulraheem Alshareef,Bandar A. Suliman,Saleh A. Alqahtani,Abdulaziz Almalik,May Alrashed,Salam Massadeh,Salam Massadeh,Vincent Mooser,Mark Lathrop,Yaseen Arabi,Yaseen Arabi,Hamdi Mbarek,Chadi Saad,Wadha Al-Muftah,Radja Badji,Asma Al Thani,Said I. Ismail,Ali G. Gharavi,Malak Abedalthagafi,J. Brent Richards,David Goldstein,Krzysztof Kiryluk +53 more
TL;DR: In this article, rare predicted loss-of-function (pLOF) variants across 13 candidate genes in TLR3- and IRF7-dependent type I IFN pathways explain up to 3.5% of severe COVID-19 cases.
Journal ArticleDOI
The 'serious' factor in germline modification.
TL;DR: It could be argued that a human rights framework, by way of its legally binding nature and its globally accepted norms and values, provides a more universal foundation for discussions of the ethical, legal and social implications of emerging or disruptive technologies.
Journal ArticleDOI
A step forward for data protection and biomedical research.
TL;DR: Because the SAP prespecified use of all data without selection, averaging blood pressure responses for both the low-dose and high-dose periods, primary analyses under-represent the true superiority of spironolactone at the end of each drug cycle.
Journal ArticleDOI
Clinical trial transparency and orphan drug development: recent trends in data sharing by the pharmaceutical industry.
TL;DR: Major developments in clinical trial transparency between January and June 2013 are summarized and the composition of datasets released by GlaxoSmithKline are analyzed to find data currently listed is diverse and could be promising for researchers interested in rare disease treatment.